Acceptability of risk-stratified breast screening: Effect of the order of presenting risk and benefit information.
Acceptability
breast screening
cancer screening
risk-stratified screening
Journal
Journal of medical screening
ISSN: 1475-5793
Titre abrégé: J Med Screen
Pays: England
ID NLM: 9433359
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
pubmed:
3
10
2019
medline:
16
1
2021
entrez:
3
10
2019
Statut:
ppublish
Résumé
To test whether reduced-frequency risk-stratified breast screening would be perceived more favourably by transposing the order of information on benefits and risks. After reading vignettes describing non-stratified three-yearly screening and a risk-stratified alternative with five-yearly invitations for women at low risk, 698 women completed an online survey. Participants were allocated at random to information on screening benefits followed by risks, or vice versa, and asked to state preferences for either screening system. Participants also rated perceived magnitude of screening benefits and risks, and breast cancer susceptibility. Binomial logistic regression did not find order effects on preferences (p = 0.533) or perceived benefits of screening (p = 0.780). Perceived screening risks were greater when risks were presented first (p < 0.0005). Greater perceived susceptibility was associated with lower proportions preferring risk-stratified screening (15% vs. 39% in highest and lowest groups; p = 0.002), as were greater perceived screening benefits (e.g. 13% vs. 45% in highest and lowest groups; p < 0.0005). No information order effect on preferences was observed. Information order did affect screening risk perceptions. Efforts to improve perceptions may need to be more intensive than those tested. Women perceiving themselves as high risk or perceiving greater benefits of screening may be particularly averse to less frequent screening.
Identifiants
pubmed: 31575328
doi: 10.1177/0969141319877669
doi:
Types de publication
Letter
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-56Subventions
Organisme : Cancer Research UK
ID : 14134
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1418/A14134
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C7492/A17219
Pays : United Kingdom